en

PRODUCT DETAIL

Priorix-Tetra

Code 2571D
MA number 59/0298/07-S
Product Form: plv iol 50+50x0,5 ml solv. (liek.inj.skl.+striek.skl.napl.)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Mutual recognition procedure
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J07 VACCINES
J07B VIRAL VACCINES
J07BD Measles vaccines (old: Morbilli vaccines)
J07BD54 Measles, combinations with mumps, rubella and varicella, live attenuated
Shelf life: 18
Container: vial glass and pre-filled syringe glass
Route of admin.: Subcutaneous and intramuscular use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - known active substance
MA issued: 30.08.2007
Pediatric indication: Yes
Pediatric posology: Yes
SPC: SPC_Priorix Tetra_11.2022.pdf  
PIL: PIL_Priorix Tetra_11.2022.pdf  
Safety feature Yes
Data update: 11.10.2019
eu-flag.png sk-flag.png